26.74
price up icon0.34%   0.09
after-market After Hours: 26.72 -0.02 -0.07%
loading

Pfizer Inc Stock (PFE) Latest News

pulisher
10:34 AM

Bernstein cuts Pfizer stock target to $30, keeps Market Perform By Investing.com - Investing.com South Africa

10:34 AM
pulisher
10:22 AM

Bernstein cuts Pfizer stock target to $30, keeps Market Perform - Investing.com India

10:22 AM
pulisher
10:11 AM

Haleon announces board change as Pfizer reduces stake - Investing.com

10:11 AM
pulisher
10:06 AM

Haleon PLC Announces Board Change Following Pfizer Shareholding Reduction - TipRanks

10:06 AM
pulisher
08:36 AM

Summit Incurs In-Line Q4 Loss, Inks Collaboration Deal With Pfizer - Nasdaq

08:36 AM
pulisher
06:44 AM

Former CDER director joins Pfizer as new chief medical officer - The Pharma Letter

06:44 AM
pulisher
05:53 AM

The Zacks Analyst Blog Highlights Alibaba, Pfizer, MercadoLibre and SIFCO - Nasdaq

05:53 AM
pulisher
05:06 AM

Ex-CDER chief Cavazzoni rejoins Pfizer as CMO - pharmaphorum

05:06 AM
pulisher
03:00 AM

Former FDA director Patrizia Cavazzoni rejoins Pfizer - Medical Dialogues

03:00 AM
pulisher
02:06 AM

Antibody Drug Conjugates Market Growth, Trends & Forecast - openPR

02:06 AM
pulisher
Feb 24, 2025

Akeso Highlights Collaboration Between Its Partner Summit Therapeutics and Pfizer to Explore Ivonescimab in Combination with Pfizer's ADCs - The Manila Times

Feb 24, 2025
pulisher
Feb 24, 2025

Can This Summit-Pfizer Cancer Drug Combo Revolutionize Solid Tumor Treatment? - StockTitan

Feb 24, 2025
pulisher
Feb 24, 2025

Top Research Reports for Alibaba, Pfizer & MercadoLibre - Nasdaq

Feb 24, 2025
pulisher
Feb 24, 2025

Pfizer Says Patrizia Cavazzoni Will Rejoin Co As Chief Medical Officer, Executive Vice President - Marketscreener.com

Feb 24, 2025
pulisher
Feb 24, 2025

Pfizer hires ex-FDA drug chief as top doctor - The Hill

Feb 24, 2025
pulisher
Feb 24, 2025

Pfizer Hires Top FDA Official Just Weeks After She Leaves Agency - Barron's

Feb 24, 2025
pulisher
Feb 24, 2025

Pfizer names former FDA director as chief medical officer - Reuters

Feb 24, 2025
pulisher
Feb 24, 2025

CD47 Antigen Inhibitors Clinical Trial Pipeline Insights Featuring 20+ Companies | DelveInsight - GlobeNewswire Inc.

Feb 24, 2025
pulisher
Feb 24, 2025

Pfizer sets sights on Summit’s bispecific in combo with its ADCs - Yahoo Finance

Feb 24, 2025
pulisher
Feb 24, 2025

Pfizer And Summit Move Fast To Combine Ivonescimab With ADCs - News & Insights

Feb 24, 2025
pulisher
Feb 24, 2025

Summit partners with Pfizer to study bispecific, ADC combinations - BioPharma Dive

Feb 24, 2025
pulisher
Feb 24, 2025

Pfizer names former FDA director Patrizia Cavazzoni as chief medical officer - KFGO

Feb 24, 2025
pulisher
Feb 24, 2025

Pfizer names Patrizia Cavazzoni, former top FDA official, as chief medical officer - BioPharma Dive

Feb 24, 2025
pulisher
Feb 24, 2025

Pfizer Names Former FDA Drug Chief as Top Doctor - Bloomberg

Feb 24, 2025
pulisher
Feb 24, 2025

Pfizer shelves Beqvez, a Spark Therapeutics developed product - The Business Journals

Feb 24, 2025
pulisher
Feb 24, 2025

Pfizer names former FDA director Patrizia Cavazzoni as chief medical officer -February 24, 2025 at 11:13 am EST - Marketscreener.com

Feb 24, 2025
pulisher
Feb 24, 2025

Pfizer: What The Summit Therapeutics Deal Brings (NYSE:PFE) - Seeking Alpha

Feb 24, 2025
pulisher
Feb 24, 2025

Pfizer : Announces New Chief Medical Officer -February 24, 2025 at 10:35 am EST - Marketscreener.com

Feb 24, 2025
pulisher
Feb 24, 2025

Pfizer’s Beqvez decision lays bare gene therapy challenges - The Pharma Letter

Feb 24, 2025
pulisher
Feb 24, 2025

Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference - Business Wire

Feb 24, 2025
pulisher
Feb 24, 2025

Pfizer: collaboration agreement with Summit Therapeutics -February 24, 2025 at 09:56 am EST - Marketscreener.com

Feb 24, 2025
pulisher
Feb 24, 2025

Peninsula drugmaker nails heart failure drug launch in battle with Big Pharma - San Francisco Business Times

Feb 24, 2025
pulisher
Feb 24, 2025

Neuralgia Treatment Market Booming with Advanced Therapies | Growth & Future Forecast: GlaxoSmithKline PLC, - EIN News

Feb 24, 2025
pulisher
Feb 24, 2025

Sector Update: Health Care Stocks Flat to Higher Pre-Bell Monday -February 24, 2025 at 09:15 am EST - Marketscreener.com

Feb 24, 2025
pulisher
Feb 24, 2025

Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance

Feb 24, 2025
pulisher
Feb 24, 2025

Summit Therapeutics shares rise on Pfizer trial collaboration - Investing.com

Feb 24, 2025
pulisher
Feb 24, 2025

Summit Therapeutics (SMMT) Announces Clinical Trial Collaboration with Pfizer (PFE) to Evaluate Ivonescimab in Combination with Pfizer Antibody Drug Conjugates (ADCs) - StreetInsider.com

Feb 24, 2025
pulisher
Feb 24, 2025

Summit Therapeutics, Pfizer to Study Ivonescimab/ADC Combos -February 24, 2025 at 07:00 am EST - Marketscreener.com

Feb 24, 2025
pulisher
Feb 24, 2025

Pfizer drops Beqvez, leaving its gene therapy cupboard bare - pharmaphorum

Feb 24, 2025
pulisher
Feb 24, 2025

Summit Therapeutics Collaborates With Pfizer To Evaluate Ivonescimab Trial -February 24, 2025 at 06:44 am EST - Marketscreener.com

Feb 24, 2025
pulisher
Feb 24, 2025

Can This New Summit-Pfizer Cancer Drug Combo Transform Solid Tumor Treatment? - StockTitan

Feb 24, 2025
pulisher
Feb 24, 2025

Volumes spurt at Pfizer Ltd counter - Business Standard

Feb 24, 2025
pulisher
Feb 24, 2025

Pfizer shares zoom nearly 9% after marketing and supply agreement with Mylan Pharmaceuticals - The Economic Times

Feb 24, 2025
pulisher
Feb 23, 2025

Pfizer shares rise by 7% after marketing and sale pact with Mylan for two neuro therapy brands - Moneycontrol

Feb 23, 2025
pulisher
Feb 23, 2025

On Heels of FDA Nod, BridgeBio’s Rival to Blockbuster Pfizer Drug Wins European Approval - MedCity News

Feb 23, 2025
pulisher
Feb 23, 2025

Are Pharma Stocks the Hidden Gems of 2024? Unveiling Pfizer’s Potential - Jomfruland.net

Feb 23, 2025
pulisher
Feb 22, 2025

Pfizer Inc. (PFE): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts - Yahoo Finance

Feb 22, 2025
pulisher
Feb 22, 2025

Pfizer: No More GrowthStill A Worthy Dividend Buy (NYSE:PFE) - Seeking Alpha

Feb 22, 2025
pulisher
Feb 21, 2025

Pfizer Cuts Last AAV Gene Therapy Program By Taking Beqvez Off The Market - News & Insights

Feb 21, 2025
pulisher
Feb 21, 2025

Pharma giant's pullback from gene therapy puts spotlight on North Carolina operations - The Business Journals

Feb 21, 2025
pulisher
Feb 21, 2025

Pfizer Jettisons FDA-Approved Hemophilia B Gene Therapy Beqvez - CGTLive™

Feb 21, 2025
pulisher
Feb 21, 2025

Pfizer Discontinues Hemophilia Gene Therapy Beqvez As Interest Wanes - Yahoo Finance

Feb 21, 2025
pulisher
Feb 21, 2025

Pfizer shelves haemophilia gene therapy Beqvez amid low demand - Yahoo Finance

Feb 21, 2025
pulisher
Feb 21, 2025

Pfizer: Investors Won't Stick Around Forever (NYSE:PFE) - Seeking Alpha

Feb 21, 2025
pulisher
Feb 21, 2025

Ozempic, Wegovy shortage resolved; Pfizer CEO is PhRMA’s new chair - BioPharma Dive

Feb 21, 2025
pulisher
Feb 21, 2025

Pfizer stops selling hemophilia gene therapy, citing weak demand - BioPharma Dive

Feb 21, 2025
pulisher
Feb 21, 2025

An awkward moment for Pfizer’s Bourla in Washington - STAT

Feb 21, 2025
pulisher
Feb 21, 2025

Topical Drug Delivery Market Booming Innovations & Forecast 2032 with Johnson & Johnson, Pfizer Inc., GSK plc, - EIN News

Feb 21, 2025
pulisher
Feb 21, 2025

Is Pfizer Inc. (PFE) the Best Non-Tech Stock to Buy Now for Long Term? - Insider Monkey

Feb 21, 2025
pulisher
Feb 21, 2025

Capital Advisory Group Advisory Services LLC Makes New $292,000 Investment in Pfizer Inc. (NYSE:PFE) - MarketBeat

Feb 21, 2025
pulisher
Feb 21, 2025

Bradley Foster & Sargent Inc. CT Purchases 139,215 Shares of Pfizer Inc. (NYSE:PFE) - MarketBeat

Feb 21, 2025
pulisher
Feb 21, 2025

Health Rounds: Swabs as good as unpleasant speculum exam for detecting cancer-causing HPV - Marketscreener.com

Feb 21, 2025
pulisher
Feb 21, 2025

Pfizer Inc. (NYSE:PFE) is WP Advisors LLC's 5th Largest Position - MarketBeat

Feb 21, 2025
pulisher
Feb 21, 2025

Pfizer Inc. (NYSE:PFE) Shares Purchased by Kentucky Retirement Systems Insurance Trust Fund - MarketBeat

Feb 21, 2025
pulisher
Feb 21, 2025

Compass Capital Corp MA ADV Buys Shares of 49,457 Pfizer Inc. (NYSE:PFE) - MarketBeat

Feb 21, 2025
$111.53
price up icon 0.45%
drug_manufacturers_general SNY
$54.89
price up icon 2.12%
$315.63
price up icon 1.91%
drug_manufacturers_general NVS
$109.62
price up icon 0.37%
drug_manufacturers_general MRK
$91.43
price up icon 0.18%
Cap:     |  Volume (24h):